Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,967 · see citing works

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592 · see citing works

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,813 · see citing works

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 727 · see citing works

Whipple's Disease

Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651 · see citing works

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644 · see citing works

New insights into the antiviral effects of chloroquine

Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570 · see citing works

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471 · see citing works

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 465 · see citing works

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century

Rolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 404 · see citing works

Treatment of Q Fever Endocarditis

Raoult, D., Houpikian, P., Tissot‐Dupont, H., Riss, J. M., Arditi-Djiane, J., & Brouqui, P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.2.167 · Cited by 352 · see citing works

Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities

Biot, C., Daher, W., Leleu‐Chavain, N., Fandeur, T., Khalife, J., Dive, D., & Clercq, E. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601856 · Cited by 318 · see citing works

Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice

Keyaerts, E., Li, S., Vijgen, L., Rysman, E., Verbeeck, J., Ranst, M. A. V., & Maes, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-08 · Cited by 311 · see citing works

Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice

Barnard, D. L., Day, C. W., Bailey, K. W., Heiner, M., Montgomery, R. A., Lauridsen, L., Chan, P. K. S., & Sidwell, R. W. (2006) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020601700505 · Cited by 210 · see citing works

[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].

(2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0019 · Cited by 190 · see citing works

Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK

Kono, M., Tatsumi, K., Imai, A. M., Saito, K., Kuriyama, T., & Shirasawa, H. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.10.011 · Cited by 183 · see citing works

Treatment of classic Whipple's disease: from in vitro results to clinical outcome

Lagier, J., Fenollar, F., Lépidi, H., Giorgi, R., Million, M., & Raoult, D. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt310 · Cited by 150 · see citing works

Antibiotic Susceptibility of Tropheryma whipplei in MRC5 Cells

Boulos, A., Rolain, J., & Raoult, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.747-752.2004 · Cited by 146 · see citing works

Azithromycin Inhibits the Replication of Zika Virus

Bosseboeuf, E., Aubry, M., Nhan, T., Pina, J.-J. D., Rolain, J., Raoult, D., & Musso, D. (2018) · Journal of Antivirals & Antiretrovirals · doi:10.4172/1948-5964.1000173 · Cited by 131 · see citing works

Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells

Raoult, D., Drancourt, M., & Vestris, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.8.1512 · Cited by 127 · see citing works

Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach

Azim, K. F., Ahmed, S. R., Banik, A., Khan, M. M. R., Deb, A., & Somana, S. R. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100367 · Cited by 73 · see citing works

Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo

Takano, T., Katoh, Y., Doki, T., & Hohdatsu, T. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.04.016 · Cited by 60 · see citing works

Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery

Lazaridis, C., Vlachogiannis, N. I., Bakogiannis, C., Spyridopoulos, I., Stamatelopoulos, K. S., Kanakakis, I., Vassilikos, V. P., & Stellos, K. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.05.004 · Cited by 59 · see citing works

Diacerein: A potential multi-target therapeutic drug for COVID-19

de Oliveira, P. G., Termini, L., Durigon, E. L., Lepique, A. P., Sposito, A. C., & Boccardo, E. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109920 · Cited by 41 · see citing works

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al

Toumi, M., & Aballéa, S. (2020) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2020.1758390 · Cited by 18 · see citing works

COVID-19: The Case of Three Patients with the Same Diagnosis but Different Clinical and Laboratory Features

Atere, M., Singh, S., Arora, K., Khan, Z., Muzangwa, L., Bhavsar, U., & Nfonoyim, J. M. (2020) · Case Reports in Medicine · doi:10.1155/2020/9185041 · Cited by 3 · see citing works

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,357 · see citing works

Coronavirus Disease 2019–COVID-19

Dhama, K., Sharun, K., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,917 · see citing works

COVID‐19 diagnosis and management: a comprehensive review

Pascarella, G., Strumia, A., Piliego, C., Bruno, F., BUONO, R. D., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,373 · see citing works

Impact of sex and gender on COVID-19 outcomes in Europe

Gebhard, C., Regitz‐Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306 · see citing works

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J. M., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,162 · see citing works

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A. K., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,118 · see citing works

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Devaux, C. A., Rolain, J., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099 · see citing works

The epidemiology, diagnosis and treatment of COVID-19

Zhai, P., Ding, Y., Wu, X., Long, J., Zhong, Y., & Li, Y. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105955 · Cited by 1,021 · see citing works

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trialPreprint

Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 844 · see citing works

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study

Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Sevestre, J., Mailhe, M., Doudier, B., Aubry, C., Amrane, S., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101663 · Cited by 763 · see citing works

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

Sharma, A., Tiwari, S., Deb, M. K., & Marty, J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106054 · Cited by 720 · see citing works

An Update on Current Therapeutic Drugs Treating COVID-19

Wu, R., Wang, L., Kuo, H. D., Shannar, A., Peter, R. M., Chou, P. J., Li, S. N., Hudlikar, R. R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 592 · see citing works

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection

Fantini, J., Scala, C. D., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105960 · Cited by 558 · see citing works

COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation

Zabetakis, I., Lordan, R., Norton, C., & Τσούπρας, Α. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 535 · see citing works

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Boopathi, S., Poma, A. B., & Kolandaivel, P. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1758788 · Cited by 531 · see citing works

Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

Lai, C.-C., Wang, C., & Hsueh, P. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.05.013 · Cited by 488 · see citing works

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.011 · Cited by 488 · see citing works

Drug repositioning: a brief overview

Jourdan, J.-P., Bureau, R., Rochais, C., & Dallemagne, P. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13273 · Cited by 470 · see citing works

Clinical management of COVID-19

Varghese, G. M., John, R., Abi Manesh, S., Rajiv Karthik, K., & Abraham, O. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_957_20 · Cited by 497 · see citing works

Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

Giudicessi, J. R., Noseworthy, P. A., Friedman, P. A., & Ackerman, M. J. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.03.024 · Cited by 394 · see citing works

The 2019–2020 novel coronavirus (severe acute respiratory syndrome coronavirus 2) pandemic: A joint american college of academic international medicine-world academic council of emergency medicine multidisciplinary COVID-19 working group consensus paper

Stawicki, S. P., Jeanmonod, R., Miller, A., Paladino, L., Gaieski, D. F., Yaffee, A. Q., Wulf, A. D., Grover, J., Papadimos, T. J., Bloem, C. M., et al. (2020) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_86_20 · Cited by 377 · see citing works

A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2

Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M., & Halim, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761883 · Cited by 339 · see citing works

Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options

McCreary, E. K., & Pogue, J. M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa105 · Cited by 334 · see citing works

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect

Andréani, J., Bideau, M. L., Duflot, I., Jardot, P., Rolland, C., Boxberger, M., Wurtz, N., Rolain, J., Colson, P., Scola, B. L., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104228 · Cited by 320 · see citing works

The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms

Alanagreh, L., Alzoughool, F., & Atoum, M. F. M. (2020) · Pathogens · doi:10.3390/pathogens9050331 · Cited by 291 · see citing works

Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase

Mirza, M. U., & Froeyen, M. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.04.008 · Cited by 290 · see citing works

Current pharmacological treatments for COVID‐19: What's next?

Scavone, C., Brusco, S., Bertini, M., Sportiello, L., Rafaniello, C., Zoccoli, A., Berrino, L., Racagni, G., Rossi, F., & Capuano, A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15072 · Cited by 280 · see citing works

Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India

Paital, B., Das, K., & Parida, S. K. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138914 · Cited by 281 · see citing works

Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

Misra, D. P., Agarwal, V., Gasparyan, A. Y., & Zimba, O. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05073-9 · Cited by 272 · see citing works

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Biedermann, P., Banda, J. M., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30276-9 · Cited by 258 · see citing works

Antiviral Potential of Nanoparticles—Can Nanoparticles Fight Against Coronaviruses?

Gurunathan, S., Qasim, M. H., Choi, Y., Tae, J., Park, C., Hong, K., Kim, J., & Song, H. (2020) · Nanomaterials · doi:10.3390/nano10091645 · Cited by 248 · see citing works

Therapeutic management of patients with COVID-19: a systematic review

Tobaiqy, M. A., Qashqary, M. E., Aldahery, S. T., Mujallad, A., Hershan, A. A., Kamal, M. A., & Helmi, N. M. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100061 · Cited by 243 · see citing works

Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?

Sportelli, M. C., Izzi, M., Kukushkina, E. A., Hossain, S. I., Picca, R. A., Ditaranto, N., & Cioffi, N. (2020) · Nanomaterials · doi:10.3390/nano10040802 · Cited by 244 · see citing works

When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19

Erku, D., Belachew, S. A., Abrha, S., Sinnollareddy, M., Thomas, J., Steadman, K. J., & Tesfaye, W. H. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.032 · Cited by 242 · see citing works

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

Alijotas‐Reig, J., Esteve‐Valverde, E., Belizna, C. C., Selva-O’Callaghan, A., Pardos‐Gea, J., Quintana, Á., MEKINIAN, A., Anunciación-Llunell, A., & Miró‐Mur, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102569 · Cited by 236 · see citing works

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19

Hernández, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2496 · Cited by 221 · see citing works

Coronavirus lockdown helped the environment to bounce back

Arora, S., Bhaukhandi, K. D., & Mishra, P. K. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140573 · Cited by 220 · see citing works

A new threat from an old enemy: Re‑emergence of coronavirus (Review)

Docea, A. O., Tsatsakis, A. M., Albulescu, D. M., Cristea, O. M., Zlatian, O. M., Vinceti, M., Moschos, S. A., Tsoukalas, D., Γούμενου, Μ., Drakoulis, N., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4555 · Cited by 221 · see citing works

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor

Maurya, V. K., Kumar, S., Prasad, A. K., Bhatt, M. L. B., & Saxena, S. K. (2020) · VirusDisease · doi:10.1007/s13337-020-00598-8 · Cited by 218 · see citing works

Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19

Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013587.pub2 · Cited by 218 · see citing works

Hydroxychloroquine and COVID-19

Sinha, N., & Balayla, G. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137785 · Cited by 205 · see citing works

Biological and social aspects of Coronavirus Disease 2019 (COVID-19) related to oral health

Pereira, L. J., Pereira, C. V., Murata, R. M., Pardi, V., & Pereira, S. M. (2020) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2020.vol34.0041 · Cited by 199 · see citing works

Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?

Derwand, R., & Scholz, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109815 · Cited by 192 · see citing works

Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment

Cicco, S., Cicco, G., Racanelli, V., & Vacca, A. (2020) · Mediators of Inflammation · doi:10.1155/2020/7527953 · Cited by 190 · see citing works

Can melatonin reduce the severity of COVID-19 pandemic?

Shneider, A., Kudriavtsev, A. V., & Vakhrusheva, A. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1756284 · Cited by 185 · see citing works

COVID-19 and Older Adult

Morley, J. E., & Vellas, B. (2020) · The Journal of nutrition, health and aging · doi:10.1007/s12603-020-1349-9 · Cited by 173 · see citing works

High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents

Kanjanasirirat, P., Suksatu, A., Manopwisedjaroen, S., Munyoo, B., Tuchinda, P., Jearawuttanakul, K., Seemakhan, S., Charoensutthivarakul, S., Wongtrakoongate, P., Rangkasenee, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77003-3 · Cited by 174 · see citing works

Psychosocial Effects of the COVID-19 Pandemic: Large-scale Quasi-Experimental Study on Social Media

Saha, K., Torous, J., Caine, E. D., & De Choudhury, M. (2020) · Journal of Medical Internet Research · doi:10.2196/22600 · Cited by 166 · see citing works

O Coração e a COVID-19: O que o Cardiologista Precisa Saber

Costa, I. B. S. D. S., Bittar, C. S., Rizk, S. I., de Araújo, A. E., dos Santos, K. K. M., Machado, T. I. V., Andrade, F. T. D. A., González, T. B., Arévalo, A. N. G., de Almeida, J. P., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200279 · Cited by 185 · see citing works

Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development

Ita, K. B. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.010 · Cited by 164 · see citing works

Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait

Almazeedi, S. M., Al‐Youha, S., Jamal, M. H., Al‐Haddad, M., Al‐Muhaini, A., Al-Ghimlas, F., & Al-Sabah, S. K. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100448 · Cited by 164 · see citing works

COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches

Moccia, F. D., Gerbino, A., Lionetti, V., Miragoli, M., Munaron, L., Pagliaro, P., Pasqua, T., Penna, C. R. R., Rocca, C., Samaja, M., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00198-w · Cited by 160 · see citing works

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19

Perricone, C., Triggianese, P., Bartoloni, E., Cafaro, G., Bonifacio, A. F., Bursi, R., Perricone, R., & Gerli, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102468 · Cited by 157 · see citing works

Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19

Huang, J., Song, W., Huang, H., & Sun, Q. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041131 · Cited by 161 · see citing works

COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine

Alexander, P. E., Debono, V. B., Mammen, M. J., Iorio, A., Aryal, K., Deng, D., Brocard, E., & Alhazzani, W. A. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.04.016 · Cited by 157 · see citing works

Topological indices and QSPR / QSAR analysis of some antiviral drugs being investigated for the treatment of COVID ‐19 patients

Kirmani, S. A. K., Ali, P., & Azam, F. (2020) · International Journal of Quantum Chemistry · doi:10.1002/qua.26594 · Cited by 157 · see citing works

Cardiac Arrhythmias in COVID-19 Infection

Kochav, S. M., Coromilas, E. J., Nalbandian, A., Ranard, L. S., Gupta, A., Chung, M. K., Gopinathannair, R., BIVIANO, A. B., Garan, H., & Wan, E. Y. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008719 · Cited by 153 · see citing works

Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation

Keretsu, S., Bhujbal, S. P., & Cho, S. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74468-0 · Cited by 148 · see citing works

Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens

Momekov, G., & Momekova, D. B. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1775118 · Cited by 145 · see citing works

A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)

Huang, F., Li, Y., Leung, E. L., Liu, X., Liu, K., Qu, W., Lan, Y., Li, X., Yu, H., Cui, L., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104929 · Cited by 143 · see citing works

COVID-19 research: pandemic versus “paperdemic”, integrity, values and risks of the “speed science”

Dinis‐Oliveira, R. J. (2020) · Forensic Sciences Research · doi:10.1080/20961790.2020.1767754 · Cited by 130 · see citing works

A Comprehensive Review About SARS-CoV-2

Haque, S. M., Ashwaq, O., Sarief, A., & Azad John Mohamed, A. K. (2020) · Future Virology · doi:10.2217/fvl-2020-0124 · Cited by 121 · see citing works

A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease

Ferrey, A., Choi, G., Hanna, R. M., Chang, Y., Tantisattamo, E., Ivaturi, K., Park, E., Nguyen, L., Wang, B., Tonthat, S., et al. (2020) · American Journal of Nephrology · doi:10.1159/000507417 · Cited by 127 · see citing works

Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review

Hashem, A. M., Alghamdi, B. S. A., Algaissi, A. A., Alshehri, F. S., Bukhari, A. I., Alfaleh, M. A., & Memish, Z. A. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101735 · Cited by 128 · see citing works

Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents

Khadke, S., Ahmed, N., Ahmed, N., Ratts, R., Raju, S., Gallogly, M. M., Lima, M. J. G. D., & Sohail, M. R. (2020) · Virology Journal · doi:10.1186/s12985-020-01415-w · Cited by 127 · see citing works

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies

Mercurio, I., Tragni, V., Busto, F., Grassi, A., & Pierri, C. L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03580-1 · Cited by 127 · see citing works

Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection

Khorramdelazad, H., Kazemi, M. H., Najafi, A., Keykhaee, M., Emameh, R. Z., & Falak, R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104554 · Cited by 127 · see citing works

Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic

Clemente‐Suárez, V. J., Hormeño-Holgado, A. J., Jiménez, M., Benítez-Agudelo, J. C., Navarro-Jiménez, E., Perez-Palencia, N., Serrano, R. Y. M., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2020) · Vaccines · doi:10.3390/vaccines8020236 · Cited by 123 · see citing works

COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies

Rauf, A., Abu‐Izneid, T., Olatunde, A., Khalil, A. A., Alhumaydhi, F. A., Tufail, T., Shariati, M. A., Ребезов, М. Б., Almarhoon, Z. M., Mabkhot, Y. N., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218155 · Cited by 130 · see citing works

Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry

Palacios-Rápalo, S. N., Jesús‐González, L. A. D., Cordero‐Rivera, C. D., Farfán-Morales, C. N., Osuna‐Ramos, J. F., Martínez-Mier, G., Quistián-Galván, J., Muñoz-Pérez, A., Bernal-Dolores, V., del Ángel, R. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796855 · Cited by 120 · see citing works

YouTube as a source of information on COVID-19 and rheumatic disease link

Koçyiğit, B. F., Akaltun, M. S., & Şahin, A. R. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05176-3 · Cited by 120 · see citing works

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

White, N. J., Watson, J. A., Hoglund, R. M., Chan, X. H. S., Cheah, P. Y., & Tärning, J. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003252 · Cited by 119 · see citing works

DFT and molecular docking study of chloroquine derivatives as antiviral to coronavirus COVID-19

Noureddine, O., Issaoui, N., & Al-Dossary, O. M. (2020) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2020.101248 · Cited by 119 · see citing works

Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months

Li, H., Liu, Z., & Ge, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15364 · Cited by 118 · see citing works

Incidence of COVID‐19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?

Favalli, E. G., Monti, S. M., Ingegnoli, F., Balduzzi, S., Caporali, R. F., & Montecucco, C. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41388 · Cited by 118 · see citing works

Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal

Fantini, J., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106020 · Cited by 117 · see citing works

A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic

Tripathy, S., Dassarma, B., Roy, S., Chabalala, H. P., & Matsabisa, M. G. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106028 · Cited by 115 · see citing works

Pharmacists’ readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles

Basheti, I. A., Nassar, R. I., Barakat, M. M., Alqudah, R., Farha, R. K. A., Mukattash, T. L., & Saini, B. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.020 · Cited by 111 · see citing works

Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19

Talluri, S. (2020) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207323666200814132149 · Cited by 113 · see citing works

Antimicrobial Photodynamic Therapy in the Control of COVID-19

Almeida, A., Faustino, M. A. F., & Neves, M. G. P. M. S. (2020) · Antibiotics · doi:10.3390/antibiotics9060320 · Cited by 112 · see citing works

COVID-19 challenges and its therapeutics

Rehman, S. U., Rehman, S. U., & Yoo, H. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112015 · Cited by 110 · see citing works

SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19

Fiscon, G., Conte, F., Farina, L., & Paci, P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008686 · Cited by 106 · see citing works

Review article: prevention, diagnosis and management of COVID‐19 in the IBD patient

Al‐Ani, A., Prentice, R., Rentsch, C. A., Johnson, D., Ardalan, Z. S., Heerasing, N. M., Garg, M., Campbell, S., Sasadeusz, J. J., Macrae, F., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15779 · Cited by 103 · see citing works

Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2

Satarker, S., Ahuja, T. N., Banerjee, M., Vignesh Balaji, E., Dogra, S. S., Agarwal, T., & Nampoothiri, M. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00231-8 · Cited by 104 · see citing works

Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain

Escalera-Antezana, J. P., Lizon-Ferrufino, N. F., Maldonado-Alanoca, A., Alarcón-De-la-Vega, G., Alvarado-Arnez, L. E., Balderrama-Saavedra, M. A., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101653 · Cited by 103 · see citing works

Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story

Gasmi, A., Peana, M., Noor, S., Lysiuk, R., Menzel, A., Benahmed, A. G., & Bjørklund, G. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11094-4 · Cited by 103 · see citing works

ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication

Qu, Y., Wang, X., Zhu, Y., Wang, W., Wang, Y., Hu, G., Liu, C., Li, J., Ren, S., Xiao, M. Z. X., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716208 · Cited by 109 · see citing works

The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics

Abbasifard, M., & Khorramdelazad, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118097 · Cited by 99 · see citing works

FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication

Lobo-Galo, N., Terrazas-López, M., Martı́nez-Martı́nez, A., & Díaz‐Sánchez, Á. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764393 · Cited by 98 · see citing works

The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study

Fathi, M., Vakili, K. G., Sayehmiri, F., Mohamadkhani, A., Hajiesmaeili, M., Rezaei–Tavirani, M., & Eilami, O. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246190 · Cited by 103 · see citing works

Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19

Rakib, A., Paul, A., Chy, M. N. U., Sami, S. A., Baral, S. K., Majumder, M., Tareq, A. M., Amin, M. N., Shahriar, A., Uddin, M. Z., et al. (2020) · Molecules · doi:10.3390/molecules25173936 · Cited by 96 · see citing works

Treatment Considerations for COVID-19

Vijayvargiya, P., Garrigos, Z. E., Almeida, N. E. C., Gurram, P. R., Stevens, R. W., & Razonable, R. R. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.027 · Cited by 94 · see citing works

Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies

Romano, S., Galante, H., Figueira, D., Mendes, Z., & Rodrigues, A. T. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.05.024 · Cited by 84 · see citing works

Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)

Nadeem, M. S., Zamzami, M. A., Choudhry, H., Murtaza, B. N., Kazmi, I. A., Ahmad, H., & Shakoori, A. R. (2020) · Pathogens · doi:10.3390/pathogens9040307 · Cited by 93 · see citing works

An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine

Mitra, R. L., Greenstein, S. A., & Epstein, L. M. (2020) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2020.03.016 · Cited by 92 · see citing works

Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society

Kapoor, A., Pandurangi, U. M., Arora, V., Gupta, A. K., Jaswal, A., Nabar, A., Naik, A. M., Naik, N., Namboodiri, N., Vora, A. M., et al. (2020) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2020.04.003 · Cited by 92 · see citing works

A Bibliometric Network Analysis of Coronavirus during the First Eight Months of COVID-19 in 2020

Furstenau, L. B., Rabaioli, B., Sott, M. K., Cossul, D., Bender, M. S., Farina, E. M. J. D. M., Filho, F. N. B., Severo, P. P., Dohan, M. S., & Bragazzi, N. L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18030952 · Cited by 93 · see citing works

Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies

Baildya, N., Ghosh, N. N., & Chattopadhyay, A. P. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128595 · Cited by 80 · see citing works

Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application

Soto, M. E., Guarner‐Lans, V., Soria‐Castro, E., Pech, L. M., & Pérez-Torres, I. (2020) · Medicina · doi:10.3390/medicina56080386 · Cited by 80 · see citing works

Can we use hydroxychloroquine to treat COVID-19 now?

Chen, J., Liu, D., Yin, L., Zhang, L., & Lu, H. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106173 · Cited by 1 · see citing works

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine

Sahraei, Z., Shabani, M., Shokouhi, S., & Saffaei, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105945 · Cited by 234 · see citing works

Chloroquine and hydroxychloroquine as potential therapies against COVID-19

Yewange, S., Deshpande, R. R., Waghmare, N., Vidyasagar, G., Bavage, S. B., & Bavage, N. B. (2020) · Cited by 1 · see citing works

Chloroquine as a prophylactic agent against COVID-19?

Gendrot, M., Javelle, É., Clerc, A., Savini, H., & Pradines, B. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105980 · Cited by 44 · see citing works

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471 · see citing works